RenovoRx, Inc. (RNXT) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RNXT Revenue Growth
Revenue Breakdown (FY 2024)
RNXT's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
RNXT Revenue Analysis (2019–2024)
As of May 8, 2026, RenovoRx, Inc. (RNXT) generated trailing twelve-month (TTM) revenue of $928,000. The most recent quarter (Q3 2025) recorded $266,000 in revenue, down 37.0% sequentially.
Looking at the longer-term picture, RNXT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $43,000 in 2024, representing a new all-time high.
Revenue diversification analysis shows RNXT's business is primarily driven by Other Operating Segment (100%). With over half of revenue concentrated in Other Operating Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), CRIS (-13.4% YoY), and TPVG. Compare RNXT vs NKTR →
RNXT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RNXTCurrent | $928,000 | - | - | -25511.6% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 CRIS | $9M | -13.4% | -2.7% | -348.4% | |
 TPVG | $97M | - | - | 77.9% | |
 CASI | $29M | +21.7% | +47.2% | -138.8% |
RNXT Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $43K | - | $43K | 100.0% | $-10,970,000 | -25511.6% |
| 2023 | $0 | - | $0 | - | $-11,396,000 | - |
| 2022 | $0 | - | $0 | - | $-9,950,000 | - |
| 2021 | $0 | - | $0 | - | $-5,671,000 | - |
| 2020 | $0 | - | $0 | - | $-3,204,000 | - |
| 2019 | $0 | - | $0 | - | $-3,896,000 | - |
See RNXT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RNXT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RNXT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRNXT — Frequently Asked Questions
Quick answers to the most common questions about buying RNXT stock.
Is RNXT's revenue growth accelerating or slowing?
RNXT TTM revenue: $928000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RNXT's long-term revenue growth rate?
RenovoRx, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RNXT's revenue distributed by segment?
RNXT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.